共 50 条
Biomechanical modeling of transcatheter aortic valve replacement in a stenotic bicuspid aortic valve: deployments and paravalvular leakage
被引:44
作者:
Lavon, Karin
[1
]
Marom, Gil
[1
]
Bianchi, Matteo
[2
]
Halevi, Rotem
[1
]
Hamdan, Ashraf
[3
]
Morany, Adi
[1
]
Raanani, Ehud
[4
]
Bluestein, Danny
[2
]
Haj-Ali, Rami
[1
,2
]
机构:
[1] Tel Aviv Univ, Sch Mech Engn, Tel Aviv, Israel
[2] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA
[3] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel
[4] Cha Sheba Med Ctr, Dept Cardiothorac Surg, Tel Hashomer, Israel
关键词:
Bicuspid aortic valve;
Transcatheter aortic valve replacement;
Paravalvular leakage;
Finite element;
Computational fluid dynamics;
FINITE-ELEMENT-ANALYSIS;
IMPLANTATION;
SIMULATION;
TAVI;
STENOSIS;
ROOT;
GEOMETRY;
IMPACT;
COREVALVE;
TISSUE;
D O I:
10.1007/s11517-019-02012-y
中图分类号:
TP39 [计算机的应用];
学科分类号:
081203 ;
0835 ;
摘要:
Calcific aortic valve disease (CAVD) is characterized by stiffened aortic valve leaflets. Bicuspid aortic valve (BAV) is the most common congenital heart disease. Transcatheter aortic valve replacement (TAVR) is a treatment approach for CAVD where a stent with mounted bioprosthetic valve is deployed on the stenotic valve. Performing TAVR in calcified BAV patients may be associated with post-procedural complications due to the BAV asymmetrical structure. This study aims to develop refined computational models simulating the deployments of Evolut R and PRO TAVR devices in a representative calcified BAV. The paravalvular leakage (PVL) was also calculated by computational fluid dynamics simulations. Computed tomography scan of severely stenotic BAV patient was acquired. The 3D calcium deposits were generated and embedded inside a parametric model of the BAV. Deployments of the Evolut R and PRO inside the calcified BAV were simulated in five bioprosthesis leaflet orientations. The hypothesis of asymmetric and elliptic stent deployment was confirmed. Positioning the bioprosthesis commissures aligned with the native commissures yielded the lowest PVL (15.7 vs. 29.5 mL/beat). The Evolut PRO reduced the PVL in half compared with the Evolut R (15.7 vs. 28.7 mL/beat). The proposed biomechanical computational model could optimize future TAVR treatment in BAV patients.
引用
收藏
页码:2129 / 2143
页数:15
相关论文
共 50 条